World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
97
Citations
51978
World Ranking
9091
National Ranking
274

Overview

Mark W. Parsons is affiliated with the University of New South Wales in Australia. Their primary research contributions are rooted in the field of Medicine, with 660 publications, and focus significantly on subfields such as Epidemiology, Neurology, Pulmonary and Respiratory Medicine, Internal Medicine, and Rehabilitation.

Their recent published papers include:

  • Trial of Endovascular Thrombectomy for Large Ischemic Strokes, 2023, New England Journal of Medicine
  • Effect of Intravenous Tenecteplase Dose on Cerebral Reperfusion Before Thrombectomy in Patients With Large Vessel Occlusion Ischemic Stroke, 2020, JAMA
  • Colchicine in Cardiovascular Disease: In-Depth Review, 2022, Circulation
  • Endovascular thrombectomy versus standard bridging thrombolytic with endovascular thrombectomy within 4·5 h of stroke onset: an open-label, blinded-endpoint, randomised non-inferiority trial, 2022, The Lancet
  • Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2/MT): a multicentre, open-label, blinded-endpoint, randomised controlled trial, 2022, The Lancet

Their work extensively covers topics related to:

  • Acute Ischemic Stroke Management
  • Cerebrovascular and Carotid Artery Diseases
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Venous Thromboembolism Diagnosis and Management
  • Stroke Rehabilitation and Recovery
  • Intracerebral and Subarachnoid Hemorrhage Research
  • Peripheral Artery Disease Management

Mark W. Parsons frequently collaborates with a group of coauthors including Bruce Campbell, Andrew Bivard, Leonid Churilov, Timothy Kleinig, and Christopher Levi.

Their research has been published often in several prominent venues, which include:

  • Stroke
  • Frontiers in Neurology
  • Neurology
  • International Journal of Stroke
  • Stroke and Vascular Neurology

In addition to journal articles, they have contributed to book publications, including a title scheduled for 2025 called "Proposals for a Caring Economy," published by the University of Minnesota Press.

Best Publications

  • Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection

    B. C. V. Campbell;L. Churilov;N. Yassi;B. Yan

  • Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials

    Jonathan Emberson;Kennedy R Lees;Patrick Lyden;Lisa Blackwell

  • Rapid Blood-Pressure Lowering in Patients With Acute Intracerebral Hemorrhage

    Craig S. Anderson;Emma Heeley;Yining Huang;Jiguang Wang

  • Pioglitazone after Ischemic Stroke or Transient Ischemic Attack

    W. N. Kernan;C. M. Viscoli;K. L. Furie;L. H. Young

  • Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial.

    Stephen M Davis;Geoffrey A Donnan;Mark W Parsons;Christopher Levi

  • Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial.

    Craig S Anderson;Yining Huang;Ji Guang Wang;Hisatomi Arima;Hisatomi Arima

  • Persistent Poststroke Hyperglycemia Is Independently Associated With Infarct Expansion and Worse Clinical Outcome

    Tracey A. Baird;Mark W. Parsons;Thanh Phan;Ken S. Butcher

  • Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study

    Mark W. Parsons;P. Alan Barber;Patricia M. Desmond;Tracey A. Baird;Tracey A. Baird

  • A randomized trial of tenecteplase versus alteplase for acute ischemic stroke.

    Mark Parsons;Neil Spratt;Andrew Bivard;Bruce Campbell

  • Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke

    Bruce C.V. Campbell;Peter J. Mitchell;Leonid Churilov;Nawaf Yassi

  • Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial.

    Michael D Hill;Mayank Goyal;Bijoy K Menon;Raul G Nogueira

  • The independent predictive utility of computed tomography angiographic collateral status in acute ischaemic stroke

    Ferdinand Miteff;Christopher R. Levi;Christopher R. Levi;Grant A. Bateman;Neil Spratt;Neil Spratt

  • Extending thrombolysis to 4·5–9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data

    Bruce C V Campbell;Bruce C V Campbell;Henry Ma;Henry Ma;Peter A Ringleb;Mark W Parsons

  • Task‐specific training: evidence for and translation to clinical practice

    Isobelle J. Hubbard;Mark W. Parsons;Cheryl. Neilson;Leeanne M. Carey

  • Cerebral Blood Flow Is the Optimal CT Perfusion Parameter for Assessing Infarct Core

    Bruce C.V. Campbell;Søren Christensen;Christopher R. Levi;Patricia M. Desmond

  • Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke

    Craig S. Anderson;Thompson Robinson;Richard I. Lindley;Hisatomi Arima

  • Diffusion- and perfusion-weighted MRI response to thrombolysis in stroke.

    Mark W. Parsons;P. Alan Barber;Jonathon Chalk;David G. Darby

  • Implementation and outcome of thrombolysis with alteplase 3–4·5 h after an acute stroke: an updated analysis from SITS-ISTR

    Niaz Ahmed;Nils Wahlgren;Martin Grond;Michael Hennerici

  • Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data

    Bruce C V Campbell;Charles B L M Majoie;Gregory W Albers;Bijoy K Menon

  • Intensive blood pressure reduction in acute cerebralhaemorrhage trial (INTERACT): a randomised pilot trial

    Craig Anderson;Hisatomi Arima;John Chalmers;Emma Heeley

Frequent Co-Authors

Christopher R. Levi
Christopher R. Levi John Hunter Hospital
Stephen M. Davis
Stephen M. Davis University of Melbourne
Geoffrey A. Donnan
Geoffrey A. Donnan University of Melbourne
Bruce C.V. Campbell
Bruce C.V. Campbell Royal Melbourne Hospital
Patricia Desmond
Patricia Desmond University of Melbourne
Craig S. Anderson
Craig S. Anderson George Institute for Global Health
John Chalmers
John Chalmers University of New South Wales
Vincent Thijs
Vincent Thijs Florey Institute of Neuroscience and Mental Health
Tissa Wijeratne
Tissa Wijeratne La Trobe University
John Attia
John Attia University of Newcastle Australia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to a wide range of rewarding healthcare careers. In addition to the traditional MD pathway, many students consider alternative routes in related health fields. Pursuing a cheapest online master degree in healthcare administration can lead to leadership roles in hospitals and health systems, often with flexible learning options and affordable tuition.

For nursing professionals, advancing your clinical expertise is possible through the cheapest dnp program. Doctor of Nursing Practice degrees are increasingly in demand and are now widely available online, making them accessible while you continue working.

Pharmacy is another growing field, and those looking for flexibility might explore online pharmacy programs. These offerings can help you earn credentials while balancing other commitments.

Additionally, the intersection of technology and health is expanding rapidly. Earning an online degree through a health informatics program allows graduates to manage medical data and optimize patient care with advanced digital tools.

These alternative degrees can lead to fulfilling careers in healthcare, with many affordable online options to fit different goals and lifestyles.

Best Scientists Citing Mark W. Parsons

Trending Scientists